Category: About ARMA

ARMA announces appointment of new Chief Executive

The Arthritis and Musculoskeletal Alliance (ARMA) is thrilled to announce the appointment of Adrian Bradley as its new Chief Executive, starting mid-June.

Adrian BradleyAdrian joins after eight and a half years as Head of Healthier Communities at the English Football League (EFL) Trust – the national charity that represents, advises and supports a network of seventy-two charities linked to professional football clubs across England and Wales. He has extensive knowledge and experience of tackling health inequalities in some of the country’s most disadvantaged communities.…

Read more of this article

ORUK joins Obesity Health Alliance

Obesity Health AllianceThe links between poor musculoskeletal (MSK) health and obesity are well documented. 70% of people experiencing poor MSK health are overweight or obese, and obesity is an important and potentially modifiable risk factor in the onset and progression of MSK conditions. This is why we are Orthopaedic Research UK (ORUK) is delighted to be joining the Obesity Health Alliance; a coalition of over 60 organisations working together to reduce obesity by influencing Government policy.

The goal of the Obesity Health Alliance is to prevent obesity-related ill-health by supporting evidence-based population level policies to help address the wider environmental factors that lead to excess bodyweight.…

Read more of this article

Would you like to be an ARMA Trustee?

Nominations are now open for election to the ARMA Trustee Board. The deadline is Friday 23 May 2025.

Trustees are responsible for the governance, strategy and management of the charity. They contribute to the strategic development of the organisation and the delivery of its services, taking part in Board meetings and in other activities between meetings as required.

To stand for election, a candidate must be nominated by an ARMA member organisation with which they have a connection. We welcome people with either lived or learned experience of MSK.…

Read more of this article

SOMM joins MACP as Clinical Interest Group…

…and Prepares to Present at 2025 Study Day

SOMM is excited to share the news that they have officially become a Clinical Interest Group for the Musculoskeletal Association of Chartered Physiotherapists (MACP).

As part of this new collaboration, SOMM has been invited to present at the upcoming MACP 2025 Study Day, themed “Challenging Concepts in MSK”. The event will be held on Saturday 7th June 2025, from 9:00 AM to 4:30 PM, at The Studio, 7 Cannon Street, Birmingham, B2 5EP.…

Read more of this article

Lupus UK Strategy insight surveys and focus groups

Lupus UK are conducting surveys and focus groups to develop their aims and priorities for the next 5 years. They want to hear from the whole lupus community about what you want and need, including people living with lupus and those who support them personally or professionally. Your voice matters, and Lupus UK is are listening.

…

Read more of this article

Arthritis Action Impact Report 2023-24

Arthritis Action is pleased to share their Impact Report 2023-24, capturing their key achievements over the course of that year. Reaching more people than ever, the charity held over 120 group meetings, events and presentations with more than 9,000 people in attendance. Arthritis Action supported over 200,000 people through their website, raised awareness and reached over 2 million on social media, with a combined publicity and PR reach of 152 million.

You can read the full report here on the website [PDF].

NRAS 3-Year Strategy survey

The National Rheumatoid Arthritis Society (NRAS) is gearing up to launch its groundbreaking three-year strategy in 2025. To make sure this strategy truly reflects the needs and aspirations of those it serves, NRAS teamed up with TwoCan Associates to conduct an insightful survey.

By gathering the invaluable perspectives of people living with RA and JIA, as well as health professionals, NRAS is ensuring that its future initiatives will be impactful, inclusive, and driven by real-world experiences.

You can see the full report here.

ARMA responds to NHS 10-Year Plan Consultation

ARMA has submitted a response to the Government’s consultation on the NHS 10-Year Plan.

The submission was produced with ARMA members who gave their views in a series of meetings. The response calls for MSK conditions to have the long-overdue acknowledgment and equal footing alongside other long-term conditions and highlights the substantial impact that MSK conditions have on individuals’ lives, the NHS and the wider economy.

You can read ARMA’s submission here.

ORUK publishes annual Impact Report

stock imageThe latest Orthopaedic Research (ORUK) Impact Report highlights how the charity continues to make a difference by focusing its investments, partnering with others and supporting the wider MSK research ecosystem through training, events and networking. It continues to be one of the most important funders of MSK research in the UK and the only charity to cover all MSK conditions.

ORUK co-funded research projects worth over £2m in 2023/24. This research funding was allocated to diagnosis, treatment, management and prevention, and a wide range of MSK conditions affecting all body parts including cell bone and soft tissue biology, biomechanics and prosthetics, osteoarthritis, bone fractures, spinal conditions, trauma, bone cancer, rehabilitation and fibromyalgia.…

Read more of this article

ARMA welcomes new Chair

Following elections at the recent AGM, ARMA welcomed a new Chair of our board of trustees.

Speaking about his new role, ARMA Chair Chris Martey said: “I am delighted to be stepping into the role of Chair in this pivotal time for the charity, where it’s work, reach and impact is going from strength to strength. It is a privilege to be taking over the mantle from Dirk, having worked closely alongside him as Vice-Chair during the last year of his tenure.…

Read more of this article